(Q44819653)

6 December 2017

title

Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein (English)

1 reference

6 December 2017

0 references

1 reference

rabies virus

1 reference

Cammy Y Lees

1

1 reference

6 December 2017

Deborah J Briggs

2

1 reference

6 December 2017

Xianfu Wu

3

1 reference

6 December 2017

Rolan D Davis

4

1 reference

6 December 2017

Susan M Moore

5

1 reference

6 December 2017

Chandra Gordon

6

1 reference

6 December 2017

Zhiquan Xiang

7

1 reference

6 December 2017

Hildegund C J Ertl

8

1 reference

6 December 2017

De chu C Tang

9

1 reference

6 December 2017

Zhen F Fu

10

1 reference

6 December 2017

publication date

1 April 2002

1 reference

6 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Veterinary Microbiology

1 reference

6 December 2017

volume

85

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

295-303

1 reference

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

First North American field release of a vaccinia-rabies glycoprotein recombinant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Genetic to genomic vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

History of Sabin attenuated poliovirus oral live vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Vaccination onto bare skin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2801%2900523-5

7 January 2021

10.1016/S0378-1135(01)00523-5

Identifiers

DOI

1 reference

6 December 2017

1 reference